Brian Seaman, Steven Brem, Allison Fromm, Aileen Staller, Timothy McCardle, Surbhi Jain
Journal: Journal of cutaneous medicine and surgery 2012;16(1):54-60
PMID: 22417997
BACKGROUND
Merkel cell carcinoma (MCC) is a rare, highly malignant, and aggressive dermal neuroendocrine neoplasm that rarely metastasizes to the central nervous system.
OBJECTIVE
To review the current literature regarding treatment of neurometastatic MCC.
METHODS
A case of a 78-year-old male with intracranial extra-axial metastatic MCC involving the left cerebellopontine angle is presented.
RESULTS
A retrosigmoid craniectomy was performed with complete resection of the metastatic focus. Adjuvant treatment included whole-brain radiation therapy followed by etoposide and carboplatin chemotherapy. Seven months postoperatively, the patient was free of metastatic disease.
CONCLUSION
Surgical resection should be performed when feasible to prevent local recurrence. This may be followed by early adjuvant fractionated whole-brain radiotherapy and systemic chemotherapy; however, no clinical trials have been performed to demonstrate a survival benefit.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.